Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia

被引:60
作者
Casato, M
Mecucci, C
Agnello, V
Fiorilli, M
Knight, GB
Matteucci, C
Gao, L
Kay, J
机构
[1] Lahey Clin, Burlington, MA 01805 USA
[2] Univ Rome La Sapienza, Dept Clin Med, Rome, Italy
[3] Univ Perugia, I-06100 Perugia, Italy
[4] Vet Affairs Med Ctr, Bedford, MA USA
关键词
D O I
10.1182/blood.V99.6.2259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient with type II cryoglobulinemic vasculitis and hepatitis C virus (HCV) infection presented with a leukemiclike proliferation of B cells bearing marginal zone B-cell phenotypic markers. A partial trisomy 3 (bands 3q11-29) and overexpression of Bcl-2 without t(14;18) translocation was detected in the monoclonal B cells that were classic rheumatoid factor-producing B cells bearing the WA cross-idiotype. Treatment with interferon-alpha produced a complete clinical remission and synchronous marked decreases in viremia and monoclonal B-cell prevalence. This is the first report of partial trisomy 3 and Bcl-2 overexpression in type II cryoglobullinemic vasculitis associated with HCV infection. Further studies of HCV-infected patients with and without type II cryoglobulinemia are required to determine the prevalence and possible physiologic and/or pathophysiologic significance of these findings.
引用
收藏
页码:2259 / 2261
页数:3
相关论文
共 24 条
[1]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[2]   The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection [J].
Agnello, V .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 19 (01) :111-129
[3]   Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients [J].
Berger, F ;
Felman, P ;
Thieblemont, C ;
Pradier, T ;
Baseggio, L ;
Bryon, PA ;
Salles, G ;
Callet-Bauchu, E ;
Coiffier, B .
BLOOD, 2000, 95 (06) :1950-1956
[4]  
BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3
[5]  
Callet-Bauchu E, 1999, GENE CHROMOSOME CANC, V26, P221, DOI 10.1002/(SICI)1098-2264(199911)26:3<221::AID-GCC6>3.0.CO
[6]  
2-9
[7]   Distribution of the cytogenetic abnormality +i(3)(q10) in persistent polyclonal B-cell lymphocytosis: a FICTION study in three cases [J].
CalletBauchu, E ;
Renard, N ;
Gazzo, S ;
Poncet, C ;
Morel, D ;
Pages, J ;
Salles, G ;
Coeur, P ;
Felman, P .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) :531-536
[8]   Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection [J].
Casato, M ;
Agnello, V ;
Pucillo, LP ;
Knight, GB ;
Leoni, M ;
DelVecchio, S ;
Mazzilli, C ;
Antonelli, G ;
Bonomo, L .
BLOOD, 1997, 90 (10) :3865-3873
[9]  
De Re V, 2000, BLOOD, V96, P3578
[10]  
De Vita S, 2000, ARTHRITIS RHEUM, V43, P94, DOI 10.1002/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO